Breztri Aerosphere

Active Ingredient(s): Budesonide + Formoterol Fumarate + Glycopyrrolate
FDA Approved: * July 23, 2020
Pharm Company: * ASTRAZENECA AB
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Breztri Aerosphere Overview

Beclometasone/formoterol/glycopyrronium, sold under the brand name Trimbow among others, is an inhalable fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD). It contains beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide.[3][4] Side effects include oral candidiasis (a fungal infection of the mouth caused by a yeast called Candida), muscle spasms and dry mouth.[3]&...

Read more Breztri Aerosphere Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Breztri Aerosphere Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Budesonide + Formoterol Fumarate + Glycopyrrolate
  • Aerosol, Metered: 0.16mg/inh + 0.0048mg/inh + 0.009mg/inh
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (28 results)